Invasive growth: a MET-driven genetic programme for cancer and stem cells (original) (raw)

• Keller, R. Cell migration during gastrulation. Curr. Opin. Cell Biol. 17, 533–541 (2005).
  Article CAS PubMed Google Scholar
• Shook, D. & Keller, R. Mechanisms, mechanics and function of epithelial–mesenchymal transitions in early development. Mech. Dev. 120, 1351–1383 (2003).
  Article CAS PubMed Google Scholar
• Tarin, D., Thompson, E. W. & Newgreen, D. F. The fallacy of epithelial–mesenchymal transition in neoplasia. Cancer Res. 65, 5996–6000 (2005).
  Article CAS PubMed Google Scholar
• Huber, M. A., Kraut, N. & Beug, H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 17, 548–558 (2005).
  Article CAS PubMed Google Scholar
• Thiery, J. P. Epithelial–mesenchymal transitions in tumour progression. Nature Rev. Cancer 2, 442–454 (2002).
  Article CAS Google Scholar
• Thompson, E. W., Newgreen, D. F. & Tarin, D. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res. 65, 5991–5995 (2005).
  Article CAS PubMed Google Scholar
• Trusolino, L. & Comoglio, P. M. Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nature Rev. Cancer 4, 289–300 (2002).
  Article CAS Google Scholar
• Nakamura, T., Teramoto, H. & Ichihara, A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc. Natl Acad. Sci. USA 83, 6489–6493 (1986).
  Article CAS PubMed PubMed Central Google Scholar
• Stoker, M., Gherardi, E., Perryman, M. & Gray, J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327, 239–242 (1987).
  Article CAS PubMed Google Scholar
• Savagner, P., Yamada, K. M. & Thiery, J. P. The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J. Cell Biol. 137, 1403–1419 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Montesano, R., Matsumoto, K., Nakamura, T. & Orci, L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67, 901–908 (1991).
  Article CAS PubMed Google Scholar
• Brinkmann, V., Foroutan, H., Sachs, M., Weidner, K. M. & Birchmeier, W. Hepatocyte growth factor/scatter factor induces a variety of tissue- specific morphogenic programs in epithelial cells. J. Cell Biol. 131, 1573–1586 (1995).
  Article CAS PubMed Google Scholar
• Stern, C. D. et al. Epithelial scatter factor and development of the chick embryonic axis. Development 110, 1271–1284 (1990).
  Article CAS PubMed Google Scholar
• Streit, A. et al. A role for HGF/SF in neural induction and its expression in Hensen's node during gastrulation. Development 121, 813–824 (1995).
  Article CAS PubMed Google Scholar
• Andermarcher, E., Surani, M. A. & Gherardi, E. Co-expression of the HGF/SF and c-met genes during early mouse embryogenesis precedes reciprocal expression in adjacent tissues during organogenesis. Dev. Genet. 18, 254–266 (1996).
  Article CAS PubMed Google Scholar
• Sonnenberg, E., Meyer, D., Weidner, K. M. & Birchmeier, C. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J. Cell Biol. 123, 223–235 (1993).
  Article CAS PubMed Google Scholar
• Yang, Y. et al. Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J. Cell Biol. 131, 215–226 (1995).
  Article CAS PubMed Google Scholar
• Birchmeier, C. & Gherardi, E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol. 8, 404–410 (1998).
  Article CAS PubMed Google Scholar
• Maina, F. & Klein, R. Hepatocyte growth factor, a versatile signal for developing neurons. Nature Neurosci. 2, 213–217 (1999).
  Article CAS PubMed Google Scholar
• Tamagnone, L. et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 99, 71–80 (1999).
  Article CAS PubMed Google Scholar
• Giordano, S. et al. The semaphorin 4D receptor controls invasive growth by coupling with Met. Nature Cell Biol. 4, 720–724 (2002).
  Article CAS PubMed Google Scholar
• Bottaro, D. P. et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251, 802–804 (1991).
  Article CAS PubMed Google Scholar
• Naldini, L. et al. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J. 10, 2867–2878 (1991).
  Article CAS PubMed PubMed Central Google Scholar
• Iwama, A., Okano, K., Sudo, T., Matsuda, Y. & Suda, T. Molecular cloning of a novel receptor tyrosine kinase gene, STK, derived from enriched hematopoietic stem cells. Blood 83, 3160–3169 (1994).
  Article CAS PubMed Google Scholar
• Gaudino, G. et al. RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. EMBO J. 13, 3524–3532 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, M. H. et al. Identification of the ron gene product as the receptor for the human macrophage stimulating protein. Science 266, 117–119 (1994).
  Article CAS PubMed Google Scholar
• Ponzetto, C. et al. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 77, 261–271 (1994).
  Article CAS PubMed Google Scholar
• Iwama, A., Yamaguchi, N. & Suda, T. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family. EMBO J. 15, 5866–5875 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Medico, E. et al. The tyrosine kinase receptors Ron and Sea control “scattering” and morphogenesis of liver progenitor cells in vitro. Mol. Biol. Cell 7, 495–504 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Conrotto, P., Corso, S., Gamberini, S., Comoglio, P. M. & Giordano, S. Interplay between scatter factor receptors and B plexins controls invasive growth. Oncogene 23, 5131–5137 (2004).
  Article CAS PubMed Google Scholar
• Trusolino, L., Bertotti, A. & Comoglio, P. M. A signaling adapter function for α6β4 integrin in the control of HGF-dependent invasive growth. Cell 107, 643–654 (2001).
  Article CAS PubMed Google Scholar
• Santoro, M. M., Gaudino, G. & Marchisio, P. C. The MSP receptor regulates α6β4 and α3β1 integrins via 14-3–3 proteins in keratinocyte migration. Dev. Cell 5, 257–271 (2003).
  Article CAS PubMed Google Scholar
• Bertotti, A. & Comoglio, P. M. Tyrosine kinase signal specificity: lessons from the HGF receptor. Trends Biochem. Sci. 28, 527–533 (2003).
  Article CAS PubMed Google Scholar
• Rosario, M. & Birchmeier, W. How to make tubes: signaling by the Met receptor tyrosine kinase. Trends Cell Biol. 13, 328–335 (2003).
  Article CAS PubMed Google Scholar
• Schmidt, L. et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nature Genet. 16, 68–73 (1997).
  Article CAS PubMed Google Scholar
• Danilkovitch-Miagkova, A. & Zbar, B. Dysregulation of Met receptor tyrosine kinase activity in invasive tumors. J. Clin. Invest 109, 863–867 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Park, W. S. et al. Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas. Cancer Res. 59, 307–310 (1999).
  CAS PubMed Google Scholar
• Lorenzato, A. et al. Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion. Cancer Res. 62, 7025–7030 (2002).
  CAS PubMed Google Scholar
• Di Renzo, M. F. et al. Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas. Oncogene 19, 1547–1555 (2000).
  Article CAS PubMed Google Scholar
• Ferracini, R. et al. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. Oncogene 10, 739–749 (1995).
  CAS PubMed Google Scholar
• Ferracini, R. et al. Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas. Oncogene 12, 1697–1705 (1996).
  CAS PubMed Google Scholar
• Scotlandi, K. et al. Expression of Met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors. Am. J. Pathol. 149, 1209–1219 (1996).
  CAS PubMed PubMed Central Google Scholar
• Koochekpour, S. et al. Met and hepatocyte growth factor/scatter factor expression in human gliomas. Cancer Res. 57, 5391–5398 (1997).
  CAS PubMed Google Scholar
• Tuck, A. B., Park, M., Sterns, E. E., Boag, A. & Elliott, B. E. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am. J. Pathol. 148, 225–232 (1996).
  CAS PubMed PubMed Central Google Scholar
• Yao, Y. et al. Scatter factor protein levels in human breast cancers: clinicopathological and biological correlations. Am. J. Pathol. 149, 1707–1717 (1996).
  CAS PubMed PubMed Central Google Scholar
• Rong, S., Segal, S., Anver, M., Resau, J. H. & Vande, W. G. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc. Natl Acad. Sci. USA 91, 4731–4735 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Meiners, S., Brinkmann, V., Naundorf, H. & Birchmeier, W. Role of morphogenetic factors in metastasis of mammary carcinoma cells. Oncogene 16, 9–20 (1998).
  Article CAS PubMed Google Scholar
• Takayama, H. et al. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc. Natl Acad. Sci. USA 94, 701–706 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Otsuka, T. et al. c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. Cancer Res. 58, 5157–5167 (1998).
  CAS PubMed Google Scholar
• Gallego, M. I., Bierie, B. & Hennighausen, L. Targeted expression of HGF/SF in mouse mammary epithelium leads to metastatic adenosquamous carcinomas through the activation of multiple signal transduction pathways. Oncogene 22, 8498–8508 (2003).
  Article CAS PubMed Google Scholar
• Birchmeier, C., Birchmeier, W., Gherardi, E. & Vande Woude, G. F. Met, metastasis, motility and more. Nature Rev. Mol. Cell Biol. 4, 915–925 (2003).
  Article CAS Google Scholar
• Di Renzo, M. F. et al. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. Clin. Cancer Res. 1, 147–154 (1995).
  CAS PubMed Google Scholar
• Takeuchi, H. et al. c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases. Clin. Cancer Res. 9, 1480–1488 (2003).
  CAS PubMed Google Scholar
• Suzuki, K. et al. Expression of the c-met protooncogene in human hepatocellular carcinoma. Hepatology 20, 1231–1236 (1994).
  Article CAS PubMed Google Scholar
• Ueki, T., Fujimoto, J., Suzuki, T., Yamamoto, H. & Okamoto, E. Expression of hepatocyte growth factor and its receptor, the c- c--met proto-oncogene, in hepatocellular carcinoma. Hepatology 25, 619–623 (1997).
  Article CAS PubMed Google Scholar
• Peghini, P. L. et al. Overexpression of epidermal growth factor and hepatocyte growth factor receptors in a proportion of gastrinomas correlates with aggressive growth and lower curability. Clin. Cancer Res. 8, 2273–2285 (2002).
  CAS PubMed Google Scholar
• Di Renzo, M. F., Poulsom, R., Olivero, M., Comoglio, P. M. & Lemoine, N. R. Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res. 55, 1129–1138 (1995).
  CAS PubMed Google Scholar
• Amemiya, H. et al. c--Met expression in gastric cancer with liver metastasis. Oncology 63, 286–296 (2002).
  Article CAS PubMed Google Scholar
• Humphrey, P. A. et al. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. Am. J. Pathol. 147, 386–396 (1995).
  CAS PubMed PubMed Central Google Scholar
• Di Renzo, M. F. et al. Overexpression of the Met/HGF receptor in ovarian cancer. Int. J. Cancer 58, 658–662 (1994).
  Article CAS PubMed Google Scholar
• Huntsman, D., Resau, J. H., Klineberg, E. & Auersperg, N. Comparison of c-met expression in ovarian epithelial tumors and normal epithelia of the female reproductive tract by quantitative laser scan microscopy. Am. J. Pathol. 155, 343–348 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Beviglia, L., Matsumoto, K., Lin, C. S., Ziober, B. L. & Kramer, R. H. Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression. Int. J. Cancer 74, 301–309 (1997).
  Article CAS PubMed Google Scholar
• Ghoussoub, R. A. et al. Expression of c-met is a strong independent prognostic factor in breast carcinoma. Cancer 82, 1513–1520 (1998).
  Article CAS PubMed Google Scholar
• Lee, W. Y. et al. Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients. Clin. Cancer Res. 11, 2222–2228 (2005).
  Article CAS PubMed Google Scholar
• Wang, R., Ferrell, L. D., Faouzi, S., Maher, J. J. & Bishop, J. M. Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. J. Cell Biol. 153, 1023–1034 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Michieli, P. et al. Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists. Oncogene 18, 5221–5231 (1999).
  Article CAS PubMed Google Scholar
• Kankuri, E., Cholujova, D., Comajova, M., Vaheri, A. & Bizik, J. Induction of hepatocyte growth factor/scatter factor by fibroblast clustering directly promotes tumor cell invasiveness. Cancer Res. 65, 9914–9922 (2005).
  Article CAS PubMed Google Scholar
• Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105–111 (2001).
  Article CAS PubMed Google Scholar
• Huntly, B. J. & Gilliland, D. G. Leukaemia stem cells and the evolution of cancer-stem-cell research. Nature Rev. Cancer 5, 311–321 (2005).
  Article CAS Google Scholar
• Lapidot, T. et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645–648 (1994).
  Article CAS PubMed Google Scholar
• Bonnet, D. & Dick, J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med. 3, 730–737 (1997).
  Article CAS PubMed Google Scholar
• Al Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983–3988 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Kim, C. F. et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121, 823–835 (2005).
  Article CAS PubMed Google Scholar
• Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396–401 (2004).
  Article CAS PubMed Google Scholar
• Tu, S. M., Lin, S. H. & Logothetis, C. J. Stem-cell origin of metastasis and heterogeneity in solid tumours. Lancet Oncol. 3, 508–513 (2002).
  Article CAS PubMed Google Scholar
• Brabletz, T., Jung, A., Spaderna, S., Hlubek, F. & Kirchner, T. Opinion: migrating cancer stem cells- an integrated concept of malignant tumour progression. Nature Rev. Cancer 5, 744–749 (2005).
  Article CAS Google Scholar
• Kucia, M. et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 23, 879–894 (2005).
  Article CAS PubMed Google Scholar
• Thery, C., Sharpe, M. J., Batley, S. J., Stern, C. D. & Gherardi, E. Expression of HGF/SF, HGF1/MSP, and c-met suggests new functions during early chick development. Dev. Genet. 17, 90–101 (1995).
  Article CAS PubMed Google Scholar
• Bladt, F., Riethmacher, D., Isenmann, S., Aguzzi, A. & Birchmeier, C. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 376, 768–771 (1995).
  Article CAS PubMed Google Scholar
• Dietrich, S. et al. The role of SF/HGF and c-Met in the development of skeletal muscle. Development 126, 1621–1629 (1999).
  Article CAS PubMed Google Scholar
• Takayama, H., La Rochelle, W. J., Anver, M., Bockman, D. E. & Merlino, G. Scatter factor/hepatocyte growth factor as a regulator of skeletal muscle and neural crest development. Proc. Natl Acad. Sci. USA 93, 5866–5871 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Kollet, O. et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J. Clin. Invest 112, 160–169 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Rosu-Myles, M. et al. A unique population of bone marrow cells migrates to skeletal muscle via hepatocyte growth factor/c-met axis. J. Cell Sci. 118, 4343–4352 (2005).
  Article CAS PubMed Google Scholar
• Kucia, M. et al. Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ. Res. 95, 1191–1199 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Kucia, M. et al. Cells enriched in markers of neural tissue-committed stem cells reside in the bone marrow and are mobilized into the peripheral blood following stroke. Leukemia 20, 18–28 (2006).
  Article CAS PubMed Google Scholar
• Neuss, S., Becher, E., Woltje, M., Tietze, L. & Jahnen-Dechent, W. Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing. Stem Cells 22, 405–414 (2004).
  Article CAS PubMed Google Scholar
• Forte, G. et al. Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation. Stem Cells 24, 23–33 (2006).
  Article CAS PubMed Google Scholar
• Galimi, F. et al. Hepatocyte growth factor induces proliferation and differentiation of multipotent and erythroid hemopoietic progenitors. J. Cell Biol. 127, 1743–1754 (1994).
  Article CAS PubMed Google Scholar
• Weimar, I. S. et al. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+). Exp. Hematol. 26, 885–894 (1998).
  CAS PubMed Google Scholar
• Cornelison, D. D. & Wold, B. J. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev. Biol. 191, 270–283 (1997).
  Article CAS PubMed Google Scholar
• Urbanek, K. et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ. Res. 97, 663–673 (2005).
  Article CAS PubMed Google Scholar
• Di Renzo, M. F. et al. Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene 6, 1997–2003 (1991).
  CAS PubMed Google Scholar
• Prat, M. et al. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int. J. Cancer 49, 323–328 (1991).
  Article CAS PubMed Google Scholar
• Pardal, R., Clarke, M. F. & Morrison, S. J. Applying the principles of stem-cell biology to cancer. Nature Rev. Cancer 3, 895–902 (2003).
  Article CAS Google Scholar
• Mueller, M. M. & Fusenig, N. E. Friends or foes — bipolar effects of the tumour stroma in cancer. Nature Rev. Cancer 4, 839–849 (2004).
  Article CAS Google Scholar
• Ivan, M., Bond, J. A., Prat, M., Comoglio, P. M. & Wynford-Thomas, D. Activated ras and ret oncogenes induce over-expression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells. Oncogene 14, 2417–2423 (1997).
  Article CAS PubMed Google Scholar
• Gambarotta, G. et al. Ets up-regulates MET transcription. Oncogene 13, 1911–1917 (1996).
  CAS PubMed Google Scholar
• Boccaccio, C., Gaudino, G., Gambarotta, G., Galimi, F. & Comoglio, P. M. Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF. J. Biol. Chem. 269, 12846–12851 (1994).
  Article CAS PubMed Google Scholar
• Anastasi, S. et al. A natural hepatocyte growth factor/scatter factor autocrine loop in myoblast cells and the effect of the constitutive Met kinase activation on myogenic differentiation. J. Cell Biol. 137, 1057–1068 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Sharp, R. et al. Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis. Nature Med. 8, 1276–1280 (2002).
  Article CAS PubMed Google Scholar
• Jankowski, K. et al. Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy. Cancer Res. 63, 7926–7935 (2003).
  CAS PubMed Google Scholar
• Vasyutina, E. et al. CXCR4 and Gab1 cooperate to control the development of migrating muscle progenitor cells. Genes Dev. 19, 2187–2198 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Natali, P. G. et al. Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression. Br. J. Cancer 68, 746–750 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Cruz, J., Reis-Filho, J. S., Silva, P. & Lopes, J. M. Expression of c-met tyrosine kinase receptor is biologically and prognostically relevant for primary cutaneous malignant melanomas. Oncology 65, 72–82 (2003).
  Article CAS PubMed Google Scholar
• Hecht, M., Papoutsi, M., Tran, H. D., Wilting, J. & Schweigerer, L. Hepatocyte growth factor/c-Met signaling promotes the progression of experimental human neuroblastomas. Cancer Res. 64, 6109–6118 (2004).
  Article CAS PubMed Google Scholar
• Schmidt, C. et al. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373, 699–702 (1995).
  Article CAS PubMed Google Scholar
• Zheng, Y. W. & Taniguchi, H. Diversity of hepatic stem cells in the fetal and adult liver. Semin. Liver Dis. 23, 337–348 (2003).
  Article CAS PubMed Google Scholar
• Suzuki, A. et al. Clonal identification and characterization of self-renewing pluripotent stem cells in the developing liver. J. Cell Biol. 156, 173–184 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Suzuki, A., Nakauchi, H. & Taniguchi, H. Prospective isolation of multipotent pancreatic progenitors using flow-cytometric cell sorting. Diabetes 53, 2143–2152 (2004).
  Article CAS PubMed Google Scholar
• Xian, C. J., Couper, R., Howarth, G. S., Read, L. C. & Kallincos, N. C. Increased expression of HGF and c-met in rat small intestine during recovery from methotrexate-induced mucositis. Br. J. Cancer 82, 945–952 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Boccaccio, C. et al. The MET oncogene drives a genetic programme linking cancer to haemostasis. Nature 434, 396–400 (2005).
  Article CAS PubMed Google Scholar
• Boon, E. M., van der Neut, R., van de Wetering, M., Clevers, H. & Pals, S. T. Wnt signaling regulates expression of the receptor tyrosine kinase met in colorectal cancer. Cancer Res. 62, 5126–5128 (2002).
  CAS PubMed Google Scholar
• van de Wetering, M. et al. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111, 241–250 (2002).
  Article CAS PubMed Google Scholar
• Brembeck, F. H. et al. Essential role of BCL9–2 in the switch between β-catenin's adhesive and transcriptional functions. Genes Dev. 18, 2225–2230 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Zhou, B. P. et al. Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition. Nature Cell Biol. 6, 931–940 (2004).
  Article CAS PubMed Google Scholar
• Stella, M. C., Trusolino, L., Pennacchietti, S. & Comoglio, P. M. Negative feedback regulation of Met-dependent invasive growth by Notch. Mol. Cell Biol. 25, 3982–3996 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Pear, W. S. & Simon, M. C. Lasting longer without oxygen: The influence of hypoxia on Notch signaling. Cancer Cell 8, 435–437 (2005).
  Article CAS PubMed Google Scholar
• Gustafsson, M. V. et al. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev. Cell 9, 617–628 (2005).
  Article CAS PubMed Google Scholar
• Ceradini, D. J. et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nature Med. 10, 858–864 (2004).
  Article CAS PubMed Google Scholar
• Ceradini, D. J. & Gurtner, G. C. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc. Med. 15, 57–63 (2005).
  Article CAS PubMed Google Scholar
• Tepper, O. M. et al. Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood 105, 1068–1077 (2005).
  Article CAS PubMed Google Scholar
• Staller, P. et al. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 425, 307–311 (2003).
  Article CAS PubMed Google Scholar
• Muller, A. et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50–56 (2001).
  Article CAS PubMed Google Scholar
• Kang, Y. et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537–549 (2003).
  Article CAS PubMed Google Scholar
• Minn, A. J. et al. Genes that mediate breast cancer metastasis to lung. Nature 436, 518–524 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Pennacchietti, S. et al. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3, 347–361 (2003).
  Article PubMed Google Scholar
• Semenza, G. L. Targeting HIF-1 for cancer therapy. Nature Rev. Cancer 3, 721–732 (2003).
  Article CAS Google Scholar
• Scarpino, S. et al. Increased expression of Met protein is associated with up-regulation of hypoxia inducible factor-1 (HIF-1) in tumour cells in papillary carcinoma of the thyroid. J. Pathol. 202, 352–358 (2004).
  Article CAS PubMed Google Scholar
• Oh, R. R. et al. Expression of HGF/SF and Met protein is associated with genetic alterations of VHL gene in primary renal cell carcinomas. APMIS 110, 229–238 (2002).
  Article CAS PubMed Google Scholar
• Ohh, M. et al. Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein. Nature Cell Biol. 2, 423–427 (2000).
  Article CAS PubMed Google Scholar
• Koochekpour, S. et al. The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells. Mol. Cell Biol. 19, 5902–5912 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Harris, A. L. Hypoxia-a-key regulatory factor in tumour growth. Nature Rev. Cancer 2, 38–47 (2002).
  Article CAS Google Scholar
• Steeg, P. S. Angiogenesis inhibitors: motivators of metastasis? Nature Med. 9, 822–823 (2003).
  Article CAS PubMed Google Scholar
• Beachy, P. A., Karhadkar, S. S. & Berman, D. M. Tissue repair and stem cell renewal in carcinogenesis. Nature 432, 324–331 (2004).
  Article CAS PubMed Google Scholar
• Dvorak, H. F. Tumors: wounds that do not heal. N. Engl. J. Med. 315, 1650–1659 (1986).
  Article CAS PubMed Google Scholar
• Rickles, F. R. & Levine, M. N. Epidemiology of thrombosis in cancer. Acta haematol. 106, 6–12 (2001).
  Article CAS PubMed Google Scholar
• Rickles, F. R., Shoji, M. & Abe, K. The role of the hemostatic system in tumor growth, metastasis, and angiogenesis: tissue factor is a bifunctional molecule capable of inducing both fibrin deposition and angiogenesis in cancer. Int. J. Hematol. 73, 145–150 (2001).
  Article CAS PubMed Google Scholar
• Petralia, G. A., Lemoine, N. R. & Kakkar, A. K. Mechanisms of disease: the impact of antithrombotic therapy in cancer patients. Nature Clin. Pract. Oncol. 2, 356–363 (2005).
  Article CAS Google Scholar
• Palumbo, J. S. et al. Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Cancer Res. 62, 6966–6972 (2002).
  CAS PubMed Google Scholar
• Rong, Y. et al. PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma. Cancer Res. 65, 1406–1413 (2005).
  Article CAS PubMed Google Scholar
• Yu, J. L. et al. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood 105, 1734–1741 (2005).
  Article CAS PubMed Google Scholar
• Dean, M., Fojo, T. & Bates, S. Tumour stem cells and drug resistance. Nature Rev. Cancer 5, 275–284 (2005).
  Article CAS Google Scholar
• Corso, S., Comoglio, P. M. & Giordano, S. Cancer therapy: can the challenge be MET? Trends Mol. Med. 11, 284–292 (2005).
  Article CAS PubMed Google Scholar
• Smolen, G. A. et al. Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752. Proc. Natl Acad. Sci. USA 103, 2316–2321 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Michieli, P. et al. Targeting the tumor and its microenvironment by a dual-function decoy Met receptor. Cancer Cell 6, 61–73 (2004).
  Article CAS PubMed Google Scholar
• Mazzone, M. et al. An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice. J. Clin. Invest. 114, 1418–1432 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Bussolino, F. et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol. 119, 629–641 (1992).
  Article CAS PubMed Google Scholar
• Petrelli, A. et al. Ab-induced ectodomain shedding mediates HGF receptor down-regulation and hampers biological activity. Proc. Natl Acad. Sci. USA 130, 5090–5095 (2006)
  Article CAS Google Scholar
• Schaeper, U. et al. Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses. J. Cell Biol. 149, 1419–1432 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Ponzetto, C. et al. Specific uncoupling of GRB2 from the Met receptor. Differential effects on transformation and motility. J. Biol. Chem. 271, 14119–14123 (1996).
  Article CAS PubMed Google Scholar
• Royal, I., Fournier, T. M. & Park, M. Differential requirement of Grb2 and PI3-kinase in HGF/SF-induced cell motility and tubulogenesis. J. Cell Physiol. 173, 196–201 (1997).
  Article CAS PubMed Google Scholar
• Xiao, G. H. et al. Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways. Proc. Natl Acad. Sci. USA 98, 247–252 (2001).
  Article CAS PubMed Google Scholar
• Giordano, S. et al. A point mutation in the MET oncogene abrogates metastasis without affecting transformation. Proc. Natl Acad. Sci. USA 94, 13868–13872 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Boccaccio, C. et al. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature 391, 285–288 (1998).
  Article CAS PubMed Google Scholar
• Gual, P. et al. Sustained recruitment of phospholipase C-γ to Gab1 is required for HGF-induced branching tubulogenesis. Oncogene 19, 1509–1518 (2000).
  Article CAS PubMed Google Scholar
• Maroun, C. R., Naujokas, M. A., Holgado-Madruga, M., Wong, A. J. & Park, M. The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase. Mol. Cell Biol. 20, 8513–8525 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Sakkab, D. et al. Signaling of hepatocyte growth factor/scatter factor (HGF) to the small GTPase Rap1 via the large docking protein Gab1 and the adapter protein CRKL. J. Biol. Chem. 275, 10772–10778 (2000).
  Article CAS PubMed Google Scholar
• Orian-Rousseau, V., Chen, L., Sleeman, J. P., Herrlich, P. & Ponta, H. CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev. 16, 3074–3086 (2002).
  Article CAS PubMed PubMed Central Google Scholar